News & Analysis

Latest content

What’s next for patent pools? Seven IP experts reveal predictions and concerns

Thought leaders share their views on how these licensing programmes might evolve

03 January 2023

Four developments to watch out for in the mRNA patent wars this year

Disputes over vaccine technology will continue to occupy headlines in 2023

03 January 2023

ITC transparency trend highlights best practices for filing complaints

The US International Trade Commission recently started releasing letters to complainants about non-institution decisions – sign-posting to counsel how to better plead cases in 2023

03 January 2023

IAM's top 20 of 2022

As we gear-up to celebrate the new year, here’s a look back at our most popular stories over the last 12 months

30 December 2022

Brazilian patent term decision quashed and other 2022 Latin America developments

IAM looks back at some key stories from Brazil and Colombia over the last 12 months

29 December 2022

The five stories that made 2022 a pivotal year for life sciences IP

IAM looks back at the most important pharmaceuticals developments of the past 12 months

28 December 2022

Watch out for the pigs... IAM Christmas traditions

As we move into the festive period, we share our established family Christmas customs and those that are just beginning

23 December 2022

Nine vehicle OEMs under Huawei licence as frenzied deal-making closes out 2022

Chinese company also extends 2017 patent licence agreement with Nokia

23 December 2022

China’s attention on trade secrets suggests change afoot in 2023

Possibility of a more comprehensive protection system across China comes with doubts about effectiveness of administrative enforcement

22 December 2022

‘The devil is in the detail' – the Qualcomm take on patent licensing

QTL General Manager John Han speaks to IAM about essentiality checks and valuation during negotiations as well as future pool participation

22 December 2022

Unlock unlimited access to all IAM content